Table 2 Missing responses, floor effects and ceiling effects of scales of the EORTC QLQ-NMIBC24 for 541 NMIBC patients participating in UroLife
Scale | T6wk (n = 541) | T3mo (n = 471) | T15mo (n = 423) | ||||||
|---|---|---|---|---|---|---|---|---|---|
% Missing | % Floor | % Ceiling | % Missing | % Floor | % Ceiling | % Missing | % Floor | % Ceiling | |
Scales | |||||||||
Urinary symptoms | 0.2 | 9.6 | 0 | 0.4 | 10.4 | 0 | 0.7 | 17.7 | 0 |
Malaise | 0 | 87.1 | 0.6 | 0.2 | 86.8 | 0.2 | 0.7 | 90.8 | 0.2 |
Future worries | 0.2 | 14.4 | 1.8 | 0.2 | 18.3 | 0.8 | 0.2 | 24.6 | 0.5 |
Bloating and flatulence | 0 | 46.0 | 0.6 | 0.2 | 43.3 | 0.6 | 0.2 | 48.0 | 0.2 |
Sexual functioning | 7.8 | 37.3 | 0.6 | 7.4 | 32.3 | 0.4 | 10.6 | 28.4 | 0.5 |
Male sexual problemsa | 10.3 | 38.3 | 7.5 | 12.8 | 37.2 | 5.7 | 12.8 | 30.5 | 8.2 |
Single items | |||||||||
Intravesical treatment issuesb | 0.6 | 74.5 | 0.4 | 0.7 | 76.1 | 0.7 | 0.5 | 84.1 | 0.5 |
Sexual intimacyc | 7.3 | 62.8 | 0.9 | 6.9 | 70.1 | 1.3 | 7.4 | 70.5 | 0.5 |
Risk of contaminating partner | 7.7 | 52.6 | 3.4 | 7.8 | 61.0 | 1.3 | 7.4 | 71.1 | 2.1 |
Sexual enjoyment | 9.0 | 17.5 | 3.8 | 9.1 | 14.3 | 3.0 | 8.4 | 20.5 | 3.2 |
Female sexual problemsd | 45.7 | 14.3 | 0 | 50.0 | 36.7 | 6.7 | 41.4 | 44.8 | 0 |